Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028-study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation - Costiniuk, C T; Saneei, Z; Routy, J P; Margolese, S; Mandarino, E; Singer, J; Lebouché, B; Cox, J; Szabo, J; Brouillette, M J; Klein, M B; Chomont, N; Jenabian, M A (BMJ Open, 2019)